Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Search results

Found 16 matches for

The Oxford Vaccine Group is an independent multi-disciplinary clinical trials and epidemiology group based at the Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford. OVG works towards the goal of developing new and improved vaccines for the prevention of infection in adults and children.

How the Information Security Office and the National Cyber Security Centre keeps Oxford's research secure post-pandemic

Oxford University's Information Security Office (InfoSec) invited the NCSC to Oxford to thank them for the work they did that kept Oxford’s vaccine research secure.

Oxford hosts Belgian vaccine experts

Researchers from Oxford Vaccine Group and the Pandemic Sciences Institute welcomed a delegation of vaccine researchers from Belgium to further UK-Belgian collaboration on vaccine development and manufacture.

Advancing a malaria vaccine for better global health outcomes

Professor Sue Ann Costa Clemens CBE, Chair of Global Health at the Department of Paediatrics and Head of Oxford Latam Research Group – a collaboration between Oxford and Brazil, aimed at strengthening our commitment to global health – met with His Excellency Antonio Patriota, Brazilian Ambassador to the UK, to discuss the co-development of a Malaria vaccine and advance public health outcomes in Brazil.

Student wins award for Individual Excellence in Clinical Data Management

Many congratulations to Yama Farooq Mujadidi, DPhil student and Clinical Trials IT & Development Lead at the Oxford Vaccine Group, who has been awarded the prize for Individual Excellence by the Association for Clinical Data Management.

The global value of vaccination

We recently worked with Mediaplanet on the 2019 Health Awareness: Value of Vaccines campaign. The campaign features exclusive content from key thought leaders and industry voices about the critical importance of full immunisation throughout life.

Typhoid vaccine set to have 'huge impact'

A new vaccine that could prevent up to nine-in-10 cases of typhoid fever has been recommended by the World Health Organization. By James Gallagher, Health and science reporter, BBC News website

OSPREA and OVG's recruitment success for study of maternal vaccines against RSV

The Oxford Safer Pregnancy Alliance [OSPREA] and the Oxford Vaccine Group [OVG] have recently undertaken a successful recruitment drive for a study of maternal immunisation to prevent infant Respiratory Syncytial Virus [RSV] infection.

Winners at the Thames Valley Health Research Awards

Hannah Robinson and Sarah Loving from the Department of Paediatrics were recognised in the annual awards hosted by the Thames Valley Clinical Research Network

Understanding RSV, a major cause of respiratory illness in infants.

Respiratory Syncytial Virus (RSV) is one of the most common reasons for young infants to be admitted to hospital, and globally is second only to malaria as a cause of death in infants between 1 and 12 months of age. In the UK it mostly occurs from October to February, causing a wave of infections that stretch the capacity of children’s wards to their limits.

Oxford vaccine test volunteers infected with typhoid

The Oxford Vaccine Group, part of University of Oxford, gave 99 volunteers a drink laced with live Salmonella Typhi bacteria a month after vaccinating them. Between 40% and 50% of the volunteers for the trial were students, Healthcare professionals were allowed to take part if they were not in patient-facing jobs or if they were willing to take around 3-4 weeks off work to be infected

BBC: Would you trial an Ebola vaccine?

BBC's Catrin Nye visited the Oxford Vaccine Group to find out about the quest for an Ebola vaccine.

World Pneumonia Day: Making vaccines work to prevent pneumonia

Today is World Pneumonia Day!

Vaccine Knowledge Project becomes member of the World Health Organization's Vaccine Safety Net

Since July 2016 the Vaccine Knowledge Project has been a member of the World Health Organization's Vaccine Safety Net

Dr Matthew Snape wins prize for engaging the public

The 12 winners of the inaugural University of Oxford's Vice-Chancellor’s Awards for Public Engagement with Research were announced on Friday 1 July by the Vice-Chancellor, Professor Louise Richardson, in a ceremony at Merton College.

Herd Immunity: How does it work?

Dr Manish Sadarangani explains how herd immunity works and why vaccinating children is important.